Neil Solomons
Equibles does not estimate personal net worth.
About Neil Solomons
Aurinia Pharmaceuticals Inc. reported in an 8-K filed October 21, 2022 that Neil Solomons was terminated as Chief Medical Officer, effective October 31, 2022. The proxy statement of Aurinia Pharmaceuticals Inc. reports total compensation of $3,222,128 for Neil Solomons in fiscal 2022, including a base salary of $369,021. Disclosed compensation is on record for 3 fiscal years.
“On October 17, 2022, Aurinia Pharmaceuticals Inc. and Robert Huizinga, PhD RN, CNeph(C), our Executive Vice President, Research and Neil Solomons, M.D., our Chief Medical Officer, mutually agreed that Dr. Huizinga and Dr. Solomons would cease their employment with Aurinia, each effective October 31, 2022.”
Affiliation history
-
Aurinia Pharmaceuticals Inc. (AUPH)
Proxy statement
Start not stated–2022-10-31
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Aurinia Pharmaceuticals Inc. (AUPH) | Former Chief Medical Officer | $369,021 | $3,222,128 |
| 2021 | Aurinia Pharmaceuticals Inc. (AUPH) | Former Chief Medical Officer | $442,164 | $717,324 |
| 2020 | Aurinia Pharmaceuticals Inc. (AUPH) | Former Chief Medical Officer | $402,148 | $2,977,334 |